Asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with asthma and who meet following requirements 1) patient receiving SFC or ICS+ TP (without regard to other drugs) 2) patient can write down the patient-dairy of this study appropriately from the doctor's viewpoint 3) patient can understand how to use PEF-meter and use appropriately from the doctor's viewpoint 4) patient can keep the rule of this study and doctor's direction from the doctor's viewpoint 5) obtain informed consent before registration to this study 6) Patient aged 20 years and above when doctors obtain informed consent
Exclusion criteria
Exclusion criteria: 1) severe asthma like following examples patients with a past history of asthma attack with airway cannulation or respiratory arrest , CO2 excess symptom, hypoxic convulsion , syncope patients receiving steroid injection or ACTH injection during 4 weeks before registration to this study patients receiving oral steroid or beta2 agonist injection , xanthene injection during 4 weeks before registration to this study 2) patient suspected of infection which has no effective antibacterial drug or deep mycosis 3) uncontrolled diabetes mellitus , hypertension , cardiac disease or hyperthyroidism 4) tuberculosis or respiratory infection 5) patient experienced adverse effect by components of study drug or another inhaled powder medicine 6) patients who is pregnant or suspected of pregnancy , wish to get pregnant , nursing mom 7) patients who don't have ability to agree 8) inappropriate patient for this study from the doctor's viewpoint
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean variation of morning PEF | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulmonary function (FEV1, V 50,V25) Asthma Control Test Patient questionnaire Mean variation of evening PEF | — |
Countries
Japan